WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. WHO. (2019)


The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.


Keywords: TB, HIV, drug-resistant, treatment, support and care


Download Publication

Tuberculosis and HIV — Progress towards the 2020 Target. UNAIDS. (2019)


Most countries are not on track and too many people living with HIV are still dying from TB which is preventable and curable. The most vulnerable and the marginalized are still out of reach of HIV and TB services and in around 40 countries the number of TB deaths among people living with HIV is increasing. This is unacceptable.


Keywords: HIV, TB, drug-resistant, deaths



Download Publication

Multisectoral Accountability Framework to Accelerate Progress to End Tuberculosis by 2030. WHO. (2019)


In November 2017, 117 national delegations adopted the Moscow Declaration to End TB at the first WHO Global Ministerial Conference on Ending TB: A Multisectoral Response. They committed to “supporting the development of a multisectoral accountability framework” to accelerate progress to end TB. They called on WHO to develop the framework, working in close cooperation with relevant partners.

At the 71st World Health Assembly (WHA) in May 2018, Member States welcomed the WHO draft multisectoral accountability framework (hereafter referred to as the MAF-TB). The WHA also requested the Director-General to continue to develop the MAF-TB, in consultation with Member States, and working in close collaboration with partners, as well as to provide technical support for national adaptation and use of the MAF-TB.


Keywords: SDG, TB, development, funding, monitoring and reporting


Download Publication

Tuberculosis and HIV. UNAIDS. (2019)


TB is the leading cause of death among people living with HIV.


Keywords: HIV, TB, co-infection, deaths




Download Infographic

Timeline of HIV and TB. UNAIDS. (2019)


Tuberculosis is the leading cause of illness and death among people living with HIV. TB can be cured.



Keywords: HIV, TB, PLHIV, treatment



Download Infographic

Multi-Country Western Pacific Integrated HIV/TB Programme: Annual Results Report 2018. UNDP Pacific. (2019)


This was the first year of the new funding cycle for the Multi-Country Western Pacific Integrated HIV/tuberculosis (TB) Programme. The three-year (2018-2020) US$11,368,713 programme is supported by the Global Fund and aims to strengthen control of HIV and TB in 11 Pacific island countries: Cook Islands, Federated States of Micronesia, Kiribati, Nauru, Niue, Palau, Republic of Marshall Islands, Samoa, Tonga, Tuvalu and Vanuatu. The United Nations Development Programme is the programme’s Principal Recipient.

Keywords: HIV, STIs, TB, legal environment, diagnostics

Download Publication

FOCUS ON: Drug-resistant Tuberculosis. The Global Fund. (2019)


Drug-resistant TB is part of the growing challenge of antimicrobial-resistant superbugs that do not respond to existing medications, resulting in fewer treatment options and increasing mortality rates for illnesses that would ordinarily be curable – including TB. Global development partners must move faster to contain this threat of antimicrobial resistance (AMR) before it escalates to claim millions of lives around the world.

Keywords: TB, drug-resistant, treatment, diagnostic, health system



Download Publication

Global Tuberculosis Report 2019. WHO. (2019)


TB remains one of the top 10 causes of death worldwide. Millions of people continue to fall sick from TB each year. The Global TB Report 2019 provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels. It features data on disease trends and the response to the epidemic in 202 countries and territories.


The Global Report includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB (MDR-TB), TB/HIV, TB prevention, universal health coverage as well as financing. It presents progress towards targets set at the first-ever United Nations General Assembly high-level meeting on TB in 2018, that brought together heads of state, as well as the targets of the WHO End TB Strategy and the Sustainable Development Goals.


The report also includes an overview of pipelines for new TB diagnostics, drugs and vaccines. Additionally, it outlines a monitoring framework that features data on SDG indicators that can be used to identify key influences on the TB epidemic at national level and inform the multi-sectoral actions required to end the TB epidemic.

Keywords: TB/HIV, UHC, SDG, treatment, drug-resistant, financing


- Full Report


- Executive Summary


- Fact Sheets


- Graphic Country Profiles


- Country Profiles for 30 High TB Burden Countries


- Regional and Global Profiles

TB-HIV Factsheet 2018. Data Hub. (2018)


Concerted and integrated efforts are needed to prevent and address both TB and TB-HIV burden in the region.

2 out of 3 TB infections globally are in Asia and the Pacific and 60% of MDR-TB burden is in this region. Globally, Asia and the Pacific is the home for 13% of PLHIV but 20% of TB-HIV co-infections are in this region. Systematic collaboration between TB-HIV programmes will save lives and improve the quality of life of people living with and affected by HIV and TB.

Keywords: Asia Pacific, TB-HIV, treatment, co-infections


Download Factsheet

Compendium of WHO Guidelines and Associated Standards: Ensuring Optimum Delivery of the Cascade of Care for Patients with Tuberculosis, Second Edition. WHO. (2018)


The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or symptoms of TB in seeking diagnosis, treatment and care; and includes key algorithms and cross-cutting elements that are essential to a patient-centered approach in the cascade of TB care.

Keywords: TB, HIV, diagnosis, children, support



Download Publication


Data Dashboard
Highlighted publications
Calendar of events